Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 45.96 USD 4.01% Market Closed
Market Cap: 128m USD

Sol Gel Technologies Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sol Gel Technologies Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash from Operating Activities
-$5.7m
CAGR 3-Years
-26%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Operating Activities
$1.1B
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
-15%
I
InterCure Ltd
TASE:INCR
Cash from Operating Activities
-₪66.9m
CAGR 3-Years
N/A
CAGR 5-Years
-42%
CAGR 10-Years
-44%
PolyPid Ltd
NASDAQ:PYPD
Cash from Operating Activities
-$22m
CAGR 3-Years
12%
CAGR 5-Years
-5%
CAGR 10-Years
-24%
Mediwound Ltd
NASDAQ:MDWD
Cash from Operating Activities
-$14.7m
CAGR 3-Years
3%
CAGR 5-Years
-20%
CAGR 10-Years
3%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Operating Activities
₪21m
CAGR 3-Years
-13%
CAGR 5-Years
8%
CAGR 10-Years
41%
No Stocks Found

Sol Gel Technologies Ltd
Glance View

Market Cap
128m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
13.87 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Sol Gel Technologies Ltd's Cash from Operating Activities?
Cash from Operating Activities
-5.7m USD

Based on the financial report for Sep 30, 2025, Sol Gel Technologies Ltd's Cash from Operating Activities amounts to -5.7m USD.

What is Sol Gel Technologies Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
22%

Over the last year, the Cash from Operating Activities growth was 67%. The average annual Cash from Operating Activities growth rates for Sol Gel Technologies Ltd have been -26% over the past three years , 22% over the past five years .

Back to Top